Nephrocare Health Services Announces Q3 & 9M FY26 Financial Results: Revenue Grows 31.7% YoY, Adj. EBITDA Margin at 24.3%

Nephrocare Health Services Limited, Asia’s largest dialysis network under the brand “NephroPlus”, announced its unaudited Financial Results for the third quarter and nine months ended 31st December 2025. The company reported a revenue of ₹ 259.7 crore in Q3 FY26, a growth of 31.7% YoY; 9M FY26 revenue of ₹ 733.2 crore, an increase of 36.6% YoY. The Adjusted EBITDA* for Q3 FY26 was ₹ 63.1 crore, a growth of 43.0% YoY; 9M FY26 Adj. EBITDA* of ₹ 175.4 crore, an increase of 52.1% YoY. The company remains focused on its vision to enable people on dialysis worldwide lead long, happy and productive lives.